Prellis Biologics, Inc., is a biotechnology company innovating human antibody discovery through organoid & artificial intelligence enabled technology. Prellis Biologics is using its unique technology to create functioning lymph node organoids. The company's method involves using scaffolds to facilitate oxygen and nutrient exchange, which allows them to replicate the human immune system outside of the body. This approach gives them a new way to develop antibody drugs by modeling immune responses in miniature. Instead of relying solely on computational methods, Prellis Biologics can challenge these organoids with an antigen and then analyze the diverse antibody solutions produced by different blood donors, generating a vast number of potential drug candidates. This innovative strategy, which its founder refers to as "natural intelligence," provides a unique competitive advantage in the rapidly evolving field of drug discovery.